Market Research Logo

Global Blood Plasma Market - Analysis By Type (Immunoglobulins - IV+SC, Albumin, Factor VIII - Plasma Derived), By Region, By Country (2018 Edition): Opportunities and Forecast (2013-2023)

Global Blood Plasma Market - Analysis By Type (Immunoglobulins - IV+SC, Albumin, Factor VIII - Plasma Derived), By Region, By Country (2018 Edition): Opportunities and Forecast (2013-2023)

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Continuous Glucose Monitoring Device Market. The report analyzes the Global Continuous Glucose Monitoring Market By Component (Transmitter & receiver, sensor, Integrated Insulin Pump), By Demographics (Pediatric, Adult), By End user (Homecare, Hospital), By Region (North America, Europe, Asia Pacific, Rest of the world) and By Country (U.S, Canada, Germany, U.K, Japan, China, India and Brazil). The report assesses the Continuous Glucose Monitoring Device Market for the period 2013-2017 and for the forecast period 2018-2023.

According to Azoth Analytics research report “Global Continuous Glucose Monitoring Devices (CGM) Market: Analysis By Component (Transmitter & Receiver, Sensor, Integrated Insulin Pump), By Demographics, End-User, By Region, By Country (2018 Edition): Forecast to 2023”, the global market is projected to display a high growth represented by a CAGR of 21.25% during 2018 – 2023.

Over the recent years, global continuous glucose monitoring devices market has been witnessing growth, on account of several driving factors including rising incidence of chronic diabetes, increasing healthcare awareness amongst consumers, flourishing market for minimally invasive products, new device approvals along with increasing health expenditure in developing countries. Moreover, ongoing demographic shift towards geriatric population with significant population suffering from serious consequences of diabetes, is expected to propel the demand for continuous glucose monitoring devices. In this research report, the market is segmented on the basis of component type, demographics, as well as end user. By component type, the segment of transmitter & receiver is predicted to hold its dominant position in the market, and sensor is the highest growing component. Amongst the regions, North America accounts for the largest regional share in the global continuous glucose monitoring devices market in 2018. However, Asia Pacific is predicted to advance at the highest rate. Presence of vast consumer base, particularly in emerging nations such as China and India, in addition to growing per capita expenditure on healthcare is likely to drive the regional market.



Scope of the Report

Global Continuous Glucose Monitoring Devices Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)
Continuous Glucose Monitoring Devices Market – Size, Growth, Forecast
By Component – Transmitter & receiver, Sensor, Integrated Insulin Pump
By Demographics- Pediatric, Adult
By End User – Homecare, Hospital

Regional Markets – North America, Europe, Asia-Pacific and Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
Continuous Glucose Monitoring Devices Market – Size, Growth, Forecast
By Component – Transmitter & receiver, Sensor, Integrated Insulin Pump
By Demographics- Pediatric, Adult
By End User – Homecare, Hospital

Country Analysis – U.S., Canada, Germany, U.K, Japan, India, China, Brazil (Actual Period: 2013-2017, Forecast Period: 2018-2023)
Continuous Glucose Monitoring Devices Market – Size, Growth, Forecast
By Component – Transmitter & receiver, Sensor, Integrated Insulin Pump
By Demographics- Pediatric, Adult
By End User – Homecare, Hospital

Other Report Highlights
Market Dynamics – Drivers and Restraints
Market Trends
Company Share Analysis
SWOT Analysis
Porter’s Five Forces Analysis
Supply Chain Analysis
Policy and Regulatory Landscape
Company Analysis – Medtronic, Dexcom, Abbott Laboratories, AgaMatrix Inc., Integrity Applications, Senseonics Holdings, GlySens ICGM, Insulet Corporation.




1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Global Blood Plasma Market: Product Outlook
Table 1: Plasma Proteins and Diseases They Treat
5. Global Blood Plasma Market: Growth and Forecast
5.1 By Value (2013-2017)
Table 2: Global Blood Plasma Market Size, By Value, 2013-2017 (USD Billion)
Table 3: IVIG Consumption, By Selected Countries, 2015, (Kg/million population)
Table 4: Endocrine, Metabolic, Blood and Immune Disorders, DALYs Per Million, Both Sexes, All ages, 2016
Table 5: United States Blood Plasma Collection, 2013-2016, in Million Liters
Table 6: Number of Blood Collection Centers in United States, 2013-2016
Table 7: United States Healthcare Expenditure, 2013-2016
Table 8: United States Blood Plasma Export to World, 2013-2016, By Volume (In Kilogram)
Table 9: United Blood States Plasma Export to World, 2013-2016, By Value (In Billion)
Table 10: China Blood Plasma Export to World, 2013-2016, By Volume (In Kilogram)
Table 11: Worldwide Demand for factor VIII, By Volume (in IU)
Table 12: Number of People With Bleeding Disorders, Worldwide, By Specific Disease, 2016
Table 13: Number of People With Hemophilia, Worldwide, By Type, 2016
Table 14: Usage of Factor VIII (IU Per Capita), 2016
Table 15: Usage of Factor IX Per Capita (IU Per Capita), 2016
Table 16: Number of People With Hemophilia, By Top 5 Countries, 2016
Table 17: Number of Plasma Fractionation Plants, 2014
Table 18: Capacity and Throughput of The Largest Fractionators ( In Thousand Liters)
Table 19: Number of Prevalent Cases of COPD, Worldwide, 2015, (in thousands)
Table 20: Number of Deaths By Alzheimer's Diseases and Other Dementias, By Selected Countries, 2016, (Per Million of Population)
Table 21: Global Aged Population (Above 65), 2013-2017 (% of total)
Table 22: Global Aged Population (Above 65), By Country, 2017 (% of total)
Table 23: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %)
Table 24: Global Expected Healthcare Industry Outlook
Table 25: Regional Expected Healthcare Industry Growth Rate By Year 2020
Table 26: Key Factors Driving Global Healthcare Industry
5.2 By Value (2018-2023)
Table 27: Global Blood Plasma Market Size, By Value, Forecast, 2018-2023 (USD Billion)
5.3 By Company Share (2017)
Table 28: Global Blood Plasma Market Share, By Company, 2017
6. Global Blood Plasma Market Size, By Type: Breakdown (%)
Table 29: Global Blood Plasma Market Size, By Type, 2017 (%)
Table 30: Global Blood Plasma Market Size, By Type, 2023F (%)
6.1 Global Immunoglobulins (IV+SC) Market
6.1.1 By Value (2013-2023)
Table 31: Global Immunoglobulins Market, By Value, 2013-2017 (USD Billion)
Table 32: Global Immunoglobulins Market, By Value,2018-2023(USD Billion)
6.1.2 By Volume (2013-2023)
Table 33: Global Immunoglobulin Market, By Volume, 2013-2017, Volume (Tons)
Table 34: Global Immunoglobulins Market, By Volume, 2018-2023(Tons)
6.1.3 By Company Share, 2017
Table 35: Global IVIG Market Share, By Company, 2017
6.2 Global Albumin Market
6.2.1By Value (2013-2023)
Table 36: Global Albumin Market, By Value, 2013-2017 (USD Billion)
Table 37: Global Albumin Market, By Value, 2018-2023 (USD Billion)
6.2.2 By Volume (2013-2023)
Table 38: Global Albumin Market, By Volume, 2013-2017 (Tons)
Table 39: Global Albumin Market, By Volume, 2018- 2023 (Tons)
6.2.3 By Company Share, 2017
Table 40: Global Albumin Market Share, By Company, 2017
6.3 Global FVIII (pd) Market
6.3.1 By Value (2013-2023)
Table 41: Global Factor VIII (Plasmatic), By Value, 2013-2017 (USD Billion)
Table 42: Global Factor VIII (Plasmatic), By Value, 2018-2023 (USD Billion)
6.3.2 By Volume (2013-2023)
Table 43: Global Factor VIII Market, By Volume, 2013-2017 (International Units)
Table 44: Global Factor VIII Market, By Volume, 2018-2023 (International Units)
6.3.3 By Company Share, 2017
Table 45: Global FVIII (Pd) Market Share, By Company, 2017
6.4 Global Other Plasma Product Market: By Value (2013-2023)
Table 46: Other Plasma Products Market, By Value, 2013-2017 (USD Billion)
Table 47: Other Plasma Products Market, By Value, 2018-2023 (USD Billion)
6.5 Global Blood Plasma Market: Market Comparison, By Segments
Table 48: Market Comparison Chart, By Segments, 2013-2023 (USD Billion)
6.6 Global Blood Plasma Market: Market Attractiveness, By Segments
Table 49: Global Market Attractiveness, By Segments, 2023F
Table 50: Healthcare Industry Landscape, By Selected Region
7. Global Blood Plasma Market: Regional Analysis
7.1 North America Blood Plasma Market: An Analysis
7.1.1 By Value (2013-2017)
Table 51: North America Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Table 52: North America GDP per capita, current prices, 2013-2023F (In USD)
Table 53: North America population aged 65 and above, 2013-2017 (% of total)
Table 54: United States health care expenditure per capita,2013-2016(USD)
Table 55: Canada health care expenditure per capita,2013-2016(USD)
7.1.2 By Value (2018-2023)
Table 56: North America Blood Plasma Market, By Value, 2018-2023 (USD Billion)
7.2 North America Blood Plasma Market: Country Analysis
7.2.1 U.S.A Blood Plasma Market, By Value (2013-2023)
Table 57: USA Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Table 58: USA Blood Plasma Market, By Value, 2018-2023(USD Billion)
Table 59: U.S., Population ages 65 and above, 2013-2017 (% of total)
Table 60: U.S. Blood Plasma Export To The World, 2015-2016, By Volume (In Kg)
Table 61: United States health care expenditure,2013-2017(% of GDP)
7.2.2 Canada Blood Plasma Market, By Value (2013-2023)
Table 62: Canada Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Table 63: Canada Blood Plasma Market, By Value, 2018-2023(USD Billion)
Table 64: Canada, Expenditure on Health as a share of GDP, 2012-2017 (in %)
Table 65: Canada, Population ages 65 and above, 2012-2017 (% of total)
7.3 Europe Blood Plasma Market: An Analysis
7.3.1 By Value (2013-2017)
Table 66: Europe Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Table 67: Health Expenditure, By Select Country, 2016 (% of GDP)
Table 68: Europe Population ages 65 years and above (% of total population), 2013-17
Table 69: European Country Population Aged 65 and Above, 2012-2017 (% of Total)
Table 70: GDP, Europe Region, By Select Country, 2017 (In Trillion USD)
7.3.2 By Value (2018-2023)
Table 71: Europe Blood Plasma Market, By Value, 2018-2023 (USD Billion)
7.4 Europe Blood Plasma Market: Country Analysis
7.4.1 Germany Blood Plasma Market, By Value (2013-2023)
Table 72: Germany Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Table 73: Germany Blood Plasma Market, By Value, 2018-2023(USD Billion)
Table 74: Germany, Population ages 65 and above, 2012-2017 (% total)
Table 75: Germany, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
7.4.2 France Blood Plasma Market, By Value (2013-2023)
Table 76: France Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Table 77: France Blood Plasma Market, By Value, 2018-2023(USD Billion)
Table 78: France, Population Ages 65 and Above, In total Population, 2013-2017
7.4.3 Italy Blood Plasma Market, By Value (2013-2023)
Table 79: Italy Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Table 80: Italy Blood Plasma Market, By Value, 2018-2023(USD Billion)
Table 81: Italy, Population Ages 65 and Above (% of total), 2013-2017
7.5 APAC Blood Plasma Market: An Analysis
Table 82: APAC & Oceania Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Table 83: GDP Per Capita in APAC, By Selected Country, 2013 (In USD)
Table 84: GDP Per Capita in APAC, By Select Country, 2016 (In USD)
Table 85: Population ages 65 and above, By Select Country, 2017 (% of total)
Table 86: Population ages 65 and above, By Select Country, 2050 (% of total)
Table 87: APAC & Oceania Blood Plasma Market, By Value, 2018-2023 (USD Billion)
7.5.1 China Blood Plasma Market, By Value (2013-2023)
Table 88: China Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Table 89: China Blood Plasma Market, By Value, 2018-2023(USD Billion)
Table 90: China, Total Population, 2013-17 (In Billion)
Table 91: China, GDP Growth Per Year, 2015-2019F (In %)
Table 92: China, Share of Urban Population, 2012-2017 (In %)
Table 93: China, Share of Urban Population, 2012-2017 (In %)
7.5.2 Japan Blood Plasma Market, By Value (2013-2023)
Table 94: Japan Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Table 95: Japan Blood Plasma Market, By Value, 2018-2023(USD Billion)
Table 96: Japan, Consumption of IVIG, 2013-2017, (Million Vails/2.5g)
Table 97: Plasma (Domestic Plasma) Through output by Japanese Fractionators, 2013-2017, Million Liters
Table 98: Japan, Population ages 65 and above, 2012-2017 (% of total)
Table 99: Japan Healthcare Expenditure Outlook (%)
7.5.3 India Blood Plasma Market, By Value (2013-2023)
Table 100: India Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Table 101: India Blood Plasma Market, By Value, 2018-2023(USD Billion)
Table 102: India, Population ages 65 and above, 2013-2017
Table 103: India, Share of Urban Population, 2012-2017 (In %)
Table 104: India, GDP Growth Per Year, 2015-2019 (In %)
Table 105: India, Total Population, 2013-2023F (In Billion)
Table 106: India, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Table 107: India, Population ages 65 and above, 2012-2017 (% total)
7.5.4 Australia Blood Plasma Market, By Value (2013-2023)
Table 108: Australia Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Table 109: Australia Blood Plasma Market, By Value, 2018-2023(USD Billion)
Table 110: Australia, IG Demand, 2013- 2016 (Thousand Gram)
Table 111: Australia, Source Plasma Collection Growth, 2013-2016 (%)
Table 112: Australia, Population Above 65, 2013-2017 (% of Total)
Table 113: Australia, Healthcare Expenditure, 2013- 2017 (% of GDP)
7.5.5 South-East Asia Blood Plasma Market, By Value (2013-2023)
Table 114: South-East Asia Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Table 115: South-East Asia Blood Plasma Market, By Value, 2018-2023(USD Billion)
Table 116: Population Above 65, By Selected Southeast Asian Countries, 2017 (% of Total)
Table 117: Healthcare Expenditure, By Selected Southeast Asian Countries, 2015 (% of GDP)
7.6 ROW Blood Plasma Market: An Analysis
7.6.1 By Value (2013-2017)
Table 118: ROW Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Table 119: GDP Per Capita in ROW, By Select Country, 2013 (In USD)
Table 120: GDP Per Capita in ROW, By Select Country, 2017 (In USD)
Table 121: Population ages 65 and above, By Select Country, 2017 (% of total)
Table 122: Population ages 60 or above, By Select Country, 2050 (% of total)
Table 123: Latin America and Caribbean, Population ages 65 and above 2012-2017(% of total)
Table 124: Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2017 (In %)
Table 125: Middle East and North Africa, Population ages 65 and above (% of total)
Table 126: Middle East and North Africa, GDP, 2012-2017 (In USD Trillion)
7.6.2 By Value (2013-2023)
Table 127: ROW Blood Plasma Market, By Value, 2018-2023 (USD Billion)
7.7 Global Blood Plasma Market: Market Comparison, By Regions
Table 128: Regional Market Comparison Chart, 2013-2023 (USD Billion)
7.8 Global Blood Plasma Market: Market Attractiveness, By Regions
Table 129: Global Market Attractiveness, By Region, 2023F
Table 130: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %)
Table 131: Global Aged Population(Above 65), (% of total)
Table 132: Male population, 2013-2017 (In Billion)
Table 133: Number of People With Dementia (In Million)
Table 134: Grifols Plasma Fractionation Capacity Growth (In Million Litters)
8. Global Blood Plasma Market Dynamics
8.1 Drivers
8.2 Challenges
8.3 Trends
9. Blood Plasma Market: Policy and Regulatory Landscape
10. Global Blood Plasma Market: Supply Chain Analysis
11. Porter's Five Forces Analysis
12 Company Profiles
12.1 CSL Limited
Table 135: CSL Limited Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Table 136: CSL Limited, Sales, By Business Segments, 2017 (In %)
Table 137: CSL Limited, By Geographic Region, 2017 (In %)
12.2 Baxter International
Table 138: Baxter International, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Table 139: Baxter International, By Business Segments, 2017 (In %)
Table 140: Baxter International, By Geographic Region, 2017 (In %)
12.3 Grifols S.A.
Table 141: Grifols S.A, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Table 142: Grifols S.A, By Business Segments, 2017 (In %)
12.4 Octa Pharma
Table 143: OCTA Pharma, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
12.5 Emergent Bio-solutions
Table 144: Emergent Bio-Solutions, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Table 145: Emergent Bio-Solutions, By Geography, 2017 (In %)
12.6 Antaris Pharma
Table 146: Antaris Pharma, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
12.7 AMAG Pharma
Table 147: AMAG Pharma, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
12.8 Kedrion Biota Pharma
Table 148: Kedrion Bio Pharma, Sales Revenue, 2013-2017 (USD Billion)
Table 149: Kedrion Bio Pharma, Sales Revenue, By Geography, 2017 (%)
12.9 Bio delivery Science International
Table 150: Bio Delivery Science International, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
12.10 Biotest A.G.
Table 151: Biotest A.G, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Table 152: Biotest A.G, By Geography, 2017 (In %)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report